USPTO 2015–2025 USPTO PatentsView US Corporation

Conagen Inc.

USPTO PatentsView assignee record — 58 granted patents across 16 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

58
Total patents granted
16
CPC technology areas
14.6
Avg claims per patent
+42%
5-year filing velocity

Portfolio overview

Conagen Inc. has been granted 58 US utility patents between 2016 and 2025, placing Conagen Inc. at rank #5,829 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Conagen Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 40.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 34 grants, compared with 24 in the 2015–2019 window — a +42% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Conagen Inc.'s 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 16 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Conagen Inc. against peers pursuing similar technology classes.

How does Conagen compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Conagen holds 58 patents — placing it at rank #5,829 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2016–2025

05101520 2016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Conagen Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 3.4%
2017 5 8.6%
2018 10 17.2%
2019 7 12.1%
2020 15 25.9%
2021 5 8.6%
2022 7 12.1%
2023 2 3.4%
2024 4 6.9%
2025 1 1.7%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#5,829

Across all tracked assignees

Innovation Score

40.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Conagen Inc. hold?
Conagen Inc. holds 58 US granted patents filed between 2016 and 2025, spanning 16 technology areas.
What is Conagen Inc.'s Innovation Score?
Conagen Inc. has an Innovation Score of 40.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Conagen Inc. focus on?
Conagen Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 55 patents. The company has filed patents in 16 CPC subclasses total.
Is Conagen Inc.'s patent filing rate increasing or decreasing?
Conagen Inc.'s recent filing velocity is +42% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Conagen Inc.'s patents?
Conagen Inc.'s patents average 14.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Conagen Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope